Speaker Profile
Ph.D., Professor and Bioinformatics Core Director, Buck Inst.
Biography
Dr. David Furman is an academic entrepreneur committed to addressing societal and scientific challenges within the human exposome, systems medicine, translational immunology, preventative healthcare, aging biology, and precision longevity. As the Director of the Stanford 1000 Immunomes Project (Stanford University) and Professor and Director of the Bioinformatics and Data Science Core (Buck Institute for Research on Aging), Dr. Furman leads research leveraging multi-scale biology ('omics') platforms and advanced AI/ML methodologies in human cohorts. With over 15 years of specialization in exposomic mechanisms leading to age-related chronic inflammation, his multi-domain expertise includes brain aging, cardiovascular health, metabolic disease and functional aging (decline in intrinsic capacity). Dr. Furman has published over 65 scientific articles in top-tier journals such as Cell, Nature Medicine, PNAS, The Lancet, and others, has collaborated with NASA and SpaceX, and is the inventor of over 20 patents.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Michael Goldman, SFSU
PMWC Award Ceremony
• David Sinclair, Harvard
• Steve Horvath, Altos Labs
• Nir Barzilai, Albert Einstein College of Medicine
AI-Driven Biomarkers to Quantify Aging
• Chair: Alex Zhavoronkov, Insilico Medicine
• Mahdi Moqri, Harvard
• Steve Horvath, Altos Labs
• Hussain Ahamed, Ultrahuman
Epigenetic Aging Signatures in Large Human Cohorts
• Varun Dwaraka, TruDiagnostic
AI Systems for Personalized Longevity: How Biomarkers Translate into Actionable Interventions
• Chair: Nathan Price, Buck Institute
• Sherry Zhang, Buck Institute
• Ranjan Sinha, Digbi Health
• Zeenia Framroze, Alethios, Inc.
• John Ramunas, Rejuvenation Technologies
Clinical Trial Design & Functional Endpoints for Healthspan
• Nir Barzilai, Albert Einstein College of Mediciney
The data We Need For AI To Accelerate Longevity Drugs
• Martin Jensen, Gordian Biotechnology
From Genome to an AI-Drive Longevity Platform
• Wei-Wu He, Human Longevity
Wellness Wearables: The Journey to Clinical
• Hussain Ahamed, Ultrahuman
Longevity Medicine: Ambition vs Evidence in the Era of Precision Health
• Aubrey de Grey, LEV Foundation
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
• S. Jay Olshansky, University of Illinois
Evolutionary perspectives on human lifespan and healthspan
• Michael Gurven, UC Santa Barbara
